Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer

Author:

Ishii Takeshi12,Akiyama Yoshimitsu1,Shimada Shu1ORCID,Kabashima Ayano1,Asano Daisuke2,Watanabe Shuichi2,Ishikawa Yoshiya2,Ueda Hiroki2,Akahoshi Keiichi2,Ogawa Kosuke2,Ono Hiroaki2ORCID,Kudo Atsushi2,Tanabe Minoru2,Tanaka Shinji12ORCID

Affiliation:

1. Department of Molecular Oncology, Graduate School of Medicine Tokyo Medical and Dental University Tokyo Japan

2. Department of Hepato‐Biliary‐Pancreatic Surgery Graduate School of Medicine, Tokyo Medical and Dental University Tokyo Japan

Funder

Japan Agency for Medical Research and Development

Ministry of Education, Culture, Sports, Science and Technology

Princess Takamatsu Cancer Research Fund

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Reference47 articles.

1. The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990‐2017: a systematic analysis for the global burden of disease study 2017. Lancet;Collaborators GBDPC;Gastroenterol Hepatol,2019

2. Therapeutic developments in pancreatic cancer: current and future perspectives

3. Cancer statistics, 2018

4. Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

5. Cancer Epigenetics: From Mechanism to Therapy

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3